| Authors (in order) |
Schwellnus et al., (2021) |
Petracek et al., (2021) |
Petek et al., (2021) |
Moulsen et al., (2021) |
Martinez et al., (2021) |
Krzywanski et al., (2021) |
Hull et al., (2021) |
Brito et al., (2021) |
| COVID-19 status |
PCR +ve (N = 37), Positive antibodies (N = 3) |
PCR and antibody test |
Tests via PCR, antigen or antibodies |
PCR (N = 2465), Antigen (N = 234) or antibody (N = 263) testing, Asymptomatic excluded |
Asymptomatic excluded, PCR and antibody testing used |
Asymptomatic excluded |
Assumed positive (N = 76), PCR or antibody testing (N = 71), Asymptomatic excluded |
Symptomatic (N = 38), Asymptomatic (N = 16) |
| Severity of COVID-19 |
Full list of COVID symptoms |
Mild symptoms including anosmia, cough, sore throat, headache and fatigue |
Categorised symptoms as Mild, Moderate and cardio- pulmonary |
Asymptomatic (N = 887), Mild (N = 839), Moderate (N = 663), Cardio- pulmonary (N = 337) |
Preceding viral symptoms (N = 460), Asymptomatic (N = 329) |
Mild (N = 93), Moderate (N = 2) |
Not mentioned |
Not mentioned |
| Fatigue outcome |
Extensive fatigue (N = 45), Moderate fatigue (N = 30) |
40 on Wellness score, 6 months post infection diagnosed with CFS |
Exertional fatigue (N = 32), Persistent symptoms 3 weeks disease onset (N = 15) |
Assessed fatigue as mild symptoms |
Fatigue observed (N = 5) |
Tiredness (N = 62) |
N = 69 (<28 days), N = 15 (>28 days) |
1/4 symptomatic patients had fatigue |